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ABSTRACT
Objectives: To evaluate the incidence of numerical chromosomal abnormalities in the patients with early pregnancy loss 
(EPL) following in vitro fertilization, and evaluate the role of different confounders of the risk of chromosomal abnormal-
ity-related pregnancy loss.
Material and methods: A retrospective chart review of all patients from our in vitro fertilization (IVF) center who conceived 
using assisted reproduction techniques between April 2017 and 2019, who experienced a subsequent early pregnancy 
loss, and whose abortus materials were successfully karyotyped were included.
Results: Of the 243 patients experienced an early loss, the overall rate of chromosomal abnormality was 46.75%. The overall 
rate of aneuploidy in our patient group was 88.8% (64/72), whereas 6.94% (5/72) of the abnormal karyotypes were polyploid. 
The most common type of trisomy was Trisomy 16 (20.0%; 11/55) followed by Trisomy 15 (14.5%; 8/55). Univariate and 
multivariate analyses showed that maternal age (< 35 years) and the total number of retrieved oocytes per cycle (≥ 5) were 
risk factors for a chromosomal abnormality (< 0.001; < 0.05, respectively). The adjusted OR of karyotypic abnormalities was 
0.45 for the antagonist cycle type (p < 0.05), and 0.58 for frozen embryo transfer (p < 0.05).
Conclusions: Karyotypic abnormality is one of the main reasons for pregnancy loss following an IVF procedure. Although 
the pregnancy rates increased as a result of novel technologies, the ratio of EPL is still high. The implementation of pre-
implantation genetic screening techniques might lower the incidence of EPL due to chromosomal abnormalities, thus 
decreasing the burden on the physicians and the patients.
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INTRODUCTION
Early pregnancy loss (EPL) is the most frequent preg-
nancy-related complication and accounts for 10–20% of 
clinically confirmed pregnancies. Most of the cases occur 
before the 20 weeks of gestational age, and up to 50% of 
them are related to chromosomal abnormalities [1].
Although the wide use of assisted reproductive tech-
nology (ART) improved the pregnancy ratio especially in 
cases with higher maternal age, EPL is still common fol-
lowing ART due to numerous causes including medication 
administered during the process, the technique used, and 
various patient-related factors [2]. The etiologies underly-
ing the pathogenesis of EPL in the cases that underwent 
ART procedures are different from the ones that conceived 
naturally [3]. Applying for an ART procedure increases the 
expectation of pregnancy for the patients despite the in-
creased rate of EPL in this group, and the analysis of possible 
causes and taking measures for prevention are of concern 
in order to minimize the psychological and economic bur-
den for the patients. Being the most common cause of EPL 
in ART cases, chromosomal abnormalities include mostly 
numerical abnormalities, mosaicisms, and structural chro-
mosomal defects involving autosomal and/or gonosomal 
chromosomes [4].
The present retrospective study aims to explore the 
effect of different patient- and procedure-related variables 
on the risk of chromosomal abnormalities in cases that 
underwent ART and experienced an EPL. 
476
Ginekologia Polska 2021, vol. 92, no. 7
www. journals.viamedica.pl/ginekologia_polska
MATERIAL AND METHODS
We performed a cohort of 243 spontaneous miscar-
riages of a specific institution specialized in ART and in 
vitro fertilization (IVF) techniques between April 2017 and 
2019. Ethical approval was obtained from the institutional 
board. Pregnancies occurred using intracytoplasmic sperm 
injection (ICSI) and experienced an early pregnancy loss 
were scanned retrospectively, and among these, 235 were 
karyotyped successfully. Exclusion criteria included: ab-
normal karyotype of one parent, spontaneous pregnancy 
with the induction, intrauterine insemination (IUI), multiple 
pregnancies, inadequate fetal tissue for analysis, and lack of 
the consent for karyotyping.
Of the resulting 154 nonviable embryos, 72 with ab-
normal karyotype acted as the outcome group and com-
pared to the nonviable embryo group (n = 82) with nor-
mal karyotyping results in terms of variables including 
basic demographic information, procedure-related factors 
such as a previous history of frozen embryo transfer (FET) 
cancellation, type of the protocol administered for ovar-
ian stimulation, total oocytes retrieved implanted embryo 
type, sperm abnormality, the gestational week at the time 
of EPL, endometrial thickness and serum hormone levels. 
The oocyte output rate was calculated using the number 
of oocytes retrieved/AFCx100% formula. Informed consent 
was obtained from each patient, and they were informed 
that their clinical data could be used for research purposes.
IVF treatment
Of the 154 women, 37 women were diagnosed with 
unilateral or bilateral tubal obstruction. The male partners of 
73 women were diagnosed with azoospermia or oligoasthe-
noteratozoospermia. Sixteen couples had infertility-causing 
sperm and hysterosalpingography (HSG) abnormalities in 
both females and males. The remaining 60 cases were di-
agnosed with idiopathic infertility.
Natural, antagonist, and semi-antagonist protocols were 
performed for ovarian stimulation. Controlled ovarian stimu-
lation was performed using recombinant FSH (rec-FSH) 
and GnRH antagonist agents as previously described [5]. 
The dose of the stimulating agent was determined based 
on the woman’s serum hormone levels, age, BMI, and other 
patient-related characteristics according to the performing 
gynecologist’s personal experience. 10.000 IU of human cho-
rionic gonadotropin (hCG) was administered when more 
than two follicles reached a diameter of 18–20 mm. After 
32–35 hours of induction, oocyte collection was performed 
through transvaginal ultrasound-guided aspiration.
All the participants in the study group received intracy-
toplasmic sperm injection (ICSI). After the transfer of Day-3, 
Day-4, or Day-5 embryos, serum beta-hCG levels were meas-
ured on the 12–14th day of the embryo transfer and were 
accepted as a positive result for the values ≥ 10 IU. Clinical 
pregnancy was confirmed when the intrauterine gestational 
sac was detected, and the fetal heartbeat was present on 
the transvaginal USG at 21 days after the transfer. The diag-
nosis of EPL was confirmed with transvaginal ultrasonog-
raphy, and curettage of the uterine cavity was performed 
afterward. Collected samples were routinely sent to the 
genetic diagnosis center for karyotype analysis. Chorionic 
villi samples were obtained cautiously in order to avoid 
maternal contamination. Samples were subjected to karyo-
type analysis after culture, harvesting, and G-banding. More 
than 20 cells in metaphase were examined and reported.
Statistical analysis
All data were stored in a computerized database. Statisti-
cal calculations of the data were performed using the SPSS 
software package program, version 12.0 for Windows. The 
comparison of the variables between two subgroups was 
done using 2-tail Student’s t-test for independent sam-
ples. A Chi-square test was performed when appropriate. 
Univariate and multivariate analysis were used to determine 
potential risk factors and calculate the adjusted ORs for chro-
mosomal abnormalities. Quantitative data were presented 
as mean ± standard deviation (SD), and risk factors were 
reported as odds ratio (OR) and 95% confidence interval 
(CI). A p-value < 0.05 was considered statistically significant.
RESULTS
The mean age of patients was 37.66 ± 4.86 in the abnor-
mal karyotype group and 33.50 ± 5.98 in the normal karyo-
type group. The mean gestational age was 8.55 ± 1.69 weeks 
(median: 8.0 weeks) in the chromosomal abnormality group 
versus 9.07 ± 3.37 weeks (median: 8.0 weeks) in the normal 
karyotype group. In 94.63% of cases, the pregnancy termi-
nated before the 12th week of gestation. Overall cytogenetic 
results revealed that 46.75% (72/154) of the miscarriages 
showed an abnormal karyotype. 
The male to female ratio of the embryos was 1:1.8 (55/99), 
and the ratio of karyotypic abnormalities in male and female 
embryos was 56.3% and 41.4%, respectively. The overall 
rate of aneuploidy in our patient group was 88.8% (64/72), 
whereas 6.94% (5/72) of the abnormal karyotypes were 
polyploid. The most common type of trisomy was Trisomy 
16 (20.0%; 11/55) followed by Trisomy 15 (14.5%; 8/55). 
Three patients had monosomy X. Double aneuploidy was 
present in five cases. 
The baseline characteristics of the groups with nor-
mal and abnormal karyotype were summarized in Table 1. 
The frequency of abortus was 70.12% (108/154), and abnor-
mal karyotype was 61.11% (44/72) in the cases who received 
frozen embryo transfer. Microdeletions or microduplica-
tions were identified in six cases (8.33% of the identified 
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abnormalities), including three duplications, one deletion, 
and two complex abnormalities. The distribution of the 
chromosomal abnormalities among different patient char-
acteristics was shown in Figure 1.
The frequency of abnormal karyotypes in abortus 
cases was significantly higher, while the maternal age was 
>35 years. There was a statistically significant difference in the 
maternal age, baseline anti-Mullerian hormone (AMH) value, 
estradiol, and progesterone levels at the time of oocyte col-
lection, total oocytes retrieved between the two groups. The 
BMI values, the total number of pregnancy loss, the number of 
FET cancellation, endometrium thickness, number of women 
with previous pregnancy loss, oocyte output rates were simi-
lar between the groups. The results from the univariate and 
multivariate regression analyses were summarized in Table 
2. Univariate and multivariate analyses showed that maternal 
age (< 35 years) and the total number of retrieved oocytes per 
cycle (≥ 5) were risk factors for a chromosomal abnormality 
(< 0.001; < 0.05). The adjusted OR of karyotypic abnormalities 
was 0.45 for the antagonist cycle type (p < 0.05), and 0.58 for 
frozen embryo transfer (p < 0.05).
DISCUSSION
EPL is the most common pregnancy-related complica-
tion and up to 20% of clinically confirmed pregnancies end 
within the first trimester. Although the etiology underlying 
SA is highly complex and including various genetic, organic, 
and systemic factors, the presence of a chromosomal ab-
normality is the most frequently observed aspect in the 
pathogenesis. Among them, numerical abnormalities, main-
ly trisomies are the most widely observed pathologies [6].
The success of an ART procedure depends on the ratio 
of live birth, and identification of factors and evaluation of 
possible reasons causing an undesirable outcome is crucial. 
In the present study, data from multiple linear regression 
analysis showed that maternal age and oocyte numbers 
were independent predictors of chromosomal abnormality 
in the patients who underwent IVF treatment and experi-
Table 1. Comparison of the characteristics of early pregnancy loss cases with or without a fetal chromosome abnormality
Chromosomal Abnormality (n = 72) Controls (n = 82) p value
Maternal age [years] 37.66 ± 4.86 33.55 ± 5.98 < 0.0001
BMI 26.42 ± 5.09 26.21 ± 4.93 0.78
Total number of previous pregnancy loss 0.56 ± 0.94 0.41 ± 0.83 0.27
Endometrial Thickness 10.66 ± 2.05 10.32 ± 1.98 0.92
Oocyte output rate 111.81 ± 66.70 125.27 ± 74.20 0.24
Total number of oocytes retrieved 11.19 ± 10.52 17.32 ± 12.74 < 0.001
AMH level (ng/mL) 1.91 ± 3.24 2.97 ± 2.42 < 0.05
Estradiol level at the time of HCG administration (pg/mL) 2417 ± 2300 3981 ± 3634 < 0.001
Progesterone level at the time of oocyte collection (ng/mL) 0.82 ± 0.86 1.25 ± 1.20 < 0.01
Gestational week at the time of loss 8.55 ± 1.69 9.07 ± 3.37 0.52
BMI — body mass index; AMH — anti-Mullerian hormone
Figure 1. Distribution of the chromosomal abnormalities among different patient characteristics
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enced an EPL. Additional confounders DET cancellation, 
presence of a sperm abnormality, endometrial thickness 
had no impact on the chromosomal abnormality risk. 
We also found that there was a significant difference between 
the two groups in terms of AMH levels, E2 and P4 levels at 
the time of oocyte collection, the total number of collected 
oocytes whereas, the total number of previous pregnancy 
loss, body mass index (BMI), endometrial thickness, number 
of patients with a previous pregnancy loss did not differ.
In their large case series of 676 spontaneous miscarriages 
following ART protocols, Martinez et al. reported that the 
51.88% of the miscarriages after ART and 51.82% conceived 
by ICSI had an abnormal karyotype with mostly autosomal 
trisomies, among which, trisomy of the chromosome 16 was 
the most observed genotype, which is consistent with our 
findings [6]. It has been suggested that trisomies develop dur-
ing oogenesis, and acrocentric’ chromosomes 13–15, 21, and 
22 were the most affected ones as a result of failures during the 
meiosis, especially for the oocytes stayed in meiosis I phase for 
up to 40 years [7]. The frequency of triploidy was 6.94% in our 
group, which was relatively higher than the previous reports [8, 
9]. Polyploidy was observed in the abortus material obtained 
from women with a mean age of 38.4 (ranging between 32–
44 years) possibly due to increased chromosomal nondisjunc-
tion and improper spindle formation during meiosis as a result 
of advanced maternal age. The probability of dispermy might 
be excluded since the records of the IVF procedure under the 
microscope did not reveal any sign of the incident. 
Table 2. Univariate and multivariate analysis of factors related to abortus with chromosomal abnormality
Chromosomal 




(95% CI) p value
Adjusted OR
(95% CI) p value
Age [years]
< 30 4 18 Baseline variable
30–35 17 37 1.73(0.60–7.04) NS
1.69
(0.48–4.32) NS




No 54 65 Baseline variable




No 37 34 Baseline variable




8 mm 54 71 Baseline variable




Natural 27 14 Baseline variable
Antagonist 40 62 0.59(0.15–0.71) < 0.001
0.45
(0.13–0.58) < 0.05
Semi-natural 5 6 0.97(0.11–1.66) NS
0.88
(0.07–1.12) NS
Total oocytes retrieved 
≤ 5 26 15 1.56(0.88–4.25) < 0.05
1.27
(0.76–3.57) < 0.05
6–20 34 38 Baseline variable




Fresh 28 18 Baseline variable
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It has been shown that AMH levels are associated with 
the implantation rates following ART procedures [10, 11]. 
In our series, we observed that the AMH levels and the 
total number of collected oocytes in the cycle were signifi-
cantly lower in the chromosomal abnormality group. This 
might be a result of age-related decline in the levels of the 
hormone and ovarian reserve, and age-related increase in 
chromosomal abnormality rates. Thus, AMH levels could not 
be suggested as an indicator of possible chromosomal ab-
normality-related EPL. Similarly, the levels of E2 and P4 were 
also lower in the chromosomal abnormality group, possi-
bly due to age-dependent factors. It has been shown that 
aneuploidy ratio was significantly higher in women older 
than 35 years old and with lower AMH levels, even after 
age stratification, suggesting that age-related changes in 
the oocytes rather than diminished ovarian reserve might 
be causing the embryonal aneuploidy [12].
Endometrial thickness was suggested to be an indica-
tor of pregnancy outcome, and birth rates were shown 
to be higher when the endometrial thickness was above 
a limit of 8 mm [13]. In our study group, we did not observe 
a significant difference between the two groups in terms of 
endometrial thickness. Additionally, when we sub-grouped 
patients in terms of endometrial thickness and chromo-
somal abnormality, the multivariate analysis did not yield 
a significantly increased risk for this measure.
The implantation rates were shown to be higher after 
frozen single blastocyst transfer, whereas the ratio of preg-
nancy loss after frozen and fresh single blastocyst transfer 
was similar [14]. In our cases, we found that the relative risk 
of chromosomal abnormality was significantly lower in the 
frozen embryo group. Consistent with our findings, Wu et 
al. found a higher ratio of chromosomal aberration in the 
cases who underwent fresh ET procedure in their study of 
EPL cases conceived using different ART [15]. Freezing and 
elective transfer of embryos might be a factor in relatively 
lower risk, eliminating the endocrinological endometrium 
related perturbations.
The ratio of female fetuses among the abortus cases 
was significantly higher in our series in accordance with the 
previous data. Although the presence of a gender-related 
mechanism underlying these results has not been revealed 
yet, there are several possible suggestions including discrep-
ancies during the intrauterine inactivation of X-chromosome 
and presence of X-chromosomal recessive lethal mutations 
[16, 17]. However, it has been reported that maternal cell 
contamination can be the result of a higher female ratio in 
abortus materials, and the ratio of maternal contamination 
was shown to be up to 22% by a recent single-nucleotide 
polymorphism chromosomal array analysis study [18, 19].
When compared to the comprehensive worldwide data 
collected from the abortus cases conceived by ICSI, the ratio 
of fetuses with abnormal karyotyping results is slightly lower 
in our study group, suggesting that might be a cause of our 
extended exclusion criteria [9, 20]. However, the karyotyping 
method used for the screening of aborted embryos might 
be underestimating a proportion of the cases. Although the 
karyotyping technique used in the context of this study is 
a conventional golden standard method, it still bears sev-
eral limitations including lower resolution limited to larger 
chromosome segments, therefore missing microdeletions, 
microduplications and subtle rearrangements, and insuffi-
ciency in detecting mosaic cases, especially when low-level 
mosaicism is present [21]. Although novel technologies as 
array-based comparative genomic hybridization (aCGH), 
and next-generation sequencing technologies are recom-
mended for the detection of chromosomal abnormalities 
in the SA cases in order to provide better accuracy, the cost 
of the methods is relatively high [22]. 
Revealing the presence of a chromosomal aberration 
underlying the SA is of utmost importance to provide a better 
pregnancy outcome for the patient and future cases, yet, the 
etiology for almost half of the cases remains unclear. A recent 
meta-analysis by Robbins et al. reported that pathogenic vari-
ants of the genes clustered in the pathways related to gene 
expression, embryonic development, mitosis, and cell cycle 
progression, and inflammation and immunity might be caus-
ing non-aneuploid early pregnancy loss [23]. However, these 
genes can not be scanned through conventional methods 
and preimplantation genetic detection (PGD) techniques, 
and meanwhile, the routine implementation of the inves-
tigation is impractical. Implementation of a PGD procedure 
during the ART process is related to a lower rate of miscarriage 
among women between 35–37 years old, and a higher rate 
of a live-birth among women > 37 years old [24]. Although 
PGD is an alternative method that might be introduced to re-
duce the EPL rates and prevent implantation of chromosomal 
abnormality carrying embryos, hence improving the clinical 
prognosis, it is not demanded by most of the couples due to 
its higher cost. Furthermore, current PGD methods can only 
detect copy number gain or losses, and if present, some trip-
loidy, and tetraploidy cases will still remain undetected [25].
The strengths of this study present the data derived from 
elective single embryo transfer cases that allow to rule out 
the embryo related factors. As parental confounders might 
be a risk factor for fetal chromosomal abnormality-related 
abortus, we excluded the individuals with any maternal or 
paternal abnormal karyotype that can contribute to chro-
mosomal abnormalities. Additionally, we meticulously em-
braced the included cases among the pregnancy loss data 
of our center. The ratios of chromosomal abnormalities, ab-
normality types, and the chromosomes involved in trisomy 
cases were well in agreement with existing literature and 
might be a reflection of the clinical practice. Laboratory and 
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technical equipment, conditions, staff, and applied proto-
cols were the same in all cases. However, there are limitations 
to this study. We did not subgroup the cases according to 
the day of embryo transfer due to a small number of patients 
per group, making the statistical evaluation difficult; thus 
the possible effects of culture medium related factors and 
incubation duration might be undervalued.
CONCLUSIONS
The present study shows that karyotypic abnormality is 
one of the main culprits for EPL, with an increasing rate as 
a result of maternal age and other defined confounders. Of 
the chromosomal alterations, aneuploidy was the most de-
tected abnormality type in our series. Although recent ad-
vances in ART improved the pregnancy rates in patients with 
different infertility etiologies, the ratio of EPL following ART 
protocols still did not deteriorate to desirable levels. Increas-
ing the ratio of live birth after ART treatment is the expected 
outcome, and further studies and reports of different series 
are needed in order to understand the underlying etiology 
of EPL and prevent chromosomal abnormality-related losses, 
and possible birth defects. Herein, we suggest that PGD us-
ing sensitive methods is necessary notably for women older 
than the age of 35 years in order to prevent EPL incidents of 
ART pregnancy, thus prevent and lower the physiological, 
psychological, and economic burden.
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